PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy

Karin Beelen, Laurien D.C. Hoefnagel, Mark Opdam, Jelle Wesseling, J. Sanders, Andrew D. Vincent, Paul J. Van Diest, Sabine C. Linn

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences